Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.220
-0.050 (-1.53%)
May 13, 2025, 4:00 PM - Market closed
Protara Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 91.46 | 162.8 | 39.59 | 24.13 | 35.72 | 168.6 | Upgrade
|
| Short-Term Investments | 32.9 | 7.49 | 25.99 | 60.24 | 55.51 | - | Upgrade
|
| Cash & Short-Term Investments | 124.36 | 170.29 | 65.58 | 84.37 | 91.23 | 168.6 | Upgrade
|
| Cash Growth | 125.20% | 159.67% | -22.27% | -7.52% | -45.89% | 29793.26% | Upgrade
|
| Other Receivables | - | - | 0.24 | 0.49 | 0.63 | - | Upgrade
|
| Receivables | - | - | 0.24 | 0.49 | 0.63 | - | Upgrade
|
| Prepaid Expenses | 2.17 | 0.93 | 0.89 | 0.59 | 0.53 | 0.53 | Upgrade
|
| Restricted Cash | - | - | - | - | - | 0.05 | Upgrade
|
| Other Current Assets | - | 0.94 | 1.99 | 0.7 | 0.72 | 0.26 | Upgrade
|
| Total Current Assets | 126.53 | 172.16 | 68.71 | 86.15 | 93.11 | 169.44 | Upgrade
|
| Property, Plant & Equipment | 4.98 | 5.28 | 6.56 | 7.87 | 8.89 | 2.3 | Upgrade
|
| Long-Term Investments | 33.15 | - | - | 17.89 | 39.47 | - | Upgrade
|
| Goodwill | - | - | - | - | 29.52 | 29.52 | Upgrade
|
| Long-Term Deferred Charges | - | 3.25 | 2.66 | 0.08 | - | - | Upgrade
|
| Other Long-Term Assets | 3.89 | 0.77 | 1.03 | 1.31 | 1.61 | 1.91 | Upgrade
|
| Total Assets | 168.56 | 181.45 | 78.95 | 113.29 | 172.6 | 203.16 | Upgrade
|
| Accounts Payable | 2.31 | 4.43 | 2.43 | 1.59 | 0.95 | 0.91 | Upgrade
|
| Accrued Expenses | 3.54 | 5.41 | 2.73 | 3.24 | 2.49 | 1.75 | Upgrade
|
| Current Portion of Leases | 1.17 | 1.12 | 0.98 | 0.92 | 0.86 | 0.09 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 0.16 | Upgrade
|
| Total Current Liabilities | 7.02 | 10.96 | 6.15 | 5.74 | 4.3 | 2.92 | Upgrade
|
| Long-Term Leases | 3.06 | 3.36 | 4.48 | 5.47 | 6.38 | 1 | Upgrade
|
| Total Liabilities | 10.08 | 14.32 | 10.63 | 11.21 | 10.68 | 3.91 | Upgrade
|
| Common Stock | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 415.25 | 412.08 | 268.73 | 262.72 | 256.13 | 245.99 | Upgrade
|
| Retained Earnings | -256.89 | -244.98 | -200.38 | -159.96 | -94.01 | -46.76 | Upgrade
|
| Comprehensive Income & Other | 0.09 | 0 | -0.03 | -0.69 | -0.21 | - | Upgrade
|
| Shareholders' Equity | 158.48 | 167.13 | 68.32 | 102.08 | 161.91 | 199.24 | Upgrade
|
| Total Liabilities & Equity | 168.56 | 181.45 | 78.95 | 113.29 | 172.6 | 203.16 | Upgrade
|
| Total Debt | 4.23 | 4.48 | 5.47 | 6.38 | 7.24 | 1.09 | Upgrade
|
| Net Cash (Debt) | 153.29 | 165.81 | 60.11 | 95.87 | 123.46 | 167.51 | Upgrade
|
| Net Cash Growth | 206.61% | 175.83% | -37.30% | -22.34% | -26.30% | 29600.53% | Upgrade
|
| Net Cash Per Share | 5.49 | 8.05 | 5.31 | 8.51 | 10.99 | 23.16 | Upgrade
|
| Filing Date Shares Outstanding | 38.58 | 36.77 | 11.43 | 11.31 | 11.25 | 11.23 | Upgrade
|
| Total Common Shares Outstanding | 38.58 | 35.04 | 11.36 | 11.27 | 11.24 | 11.21 | Upgrade
|
| Working Capital | 119.51 | 161.19 | 62.56 | 80.41 | 88.81 | 166.52 | Upgrade
|
| Book Value Per Share | 4.11 | 4.77 | 6.01 | 9.06 | 14.41 | 17.77 | Upgrade
|
| Tangible Book Value | 158.48 | 167.13 | 68.32 | 102.08 | 132.4 | 169.73 | Upgrade
|
| Tangible Book Value Per Share | 4.11 | 4.77 | 6.01 | 9.06 | 11.78 | 15.14 | Upgrade
|
| Machinery | - | 1.5 | 1.51 | 1.42 | 1.12 | 0.66 | Upgrade
|
| Leasehold Improvements | - | 0.55 | 0.55 | 0.55 | 0.22 | 0.2 | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.